BMT: Data on 137 Bone Marrow Transplant Patients

Description Usage Format Source References Examples

Description

Data on 137 Bone Marrow Transplant Patients

Usage

1

Format

a data frame with 137 observations on the following 22 variables.

g

disease group; 1-ALL, 2-AML low-risk, 3-high-risk

T1

time (in days) to death or on study time

T2

disease-Free survival time (time to relapse, death or end of study)

delta1

death indicator; 1-Dead, 0-Alive

delta2

relapse indicator; 1-Relapsed, 0-Disease-Free

delta3

disease-Free survival indicator; 1-Dead or relapsed, 0-Alive disease-free

TA

time (in days) to acute graft-versus-host disease

deltaA

acute graft-versus-host disease indicator; 1-Developed acute graft-versus-host disease, 0-Never developed acute graft-versus-host disease

TC

time (in days) to chronic graft-versus-host disease

deltaC

chronic graft-versus-host disease indicator; 1-Developed chronic graft-versus-host disease, 0-Never developed chronic graft-versus-host disease

TP

time (in days) to return of platelets to normal levels

deltaP

platelet recovery indicator; 1-Platelets returned to normal levels, 0-Platelets never returned to normal levels

Z1

patient age in years

Z2

donor age in years

Z3

patient sex; 1-Male, 2-Female

Z4

donor sex; 1-Male, 2-Female

Z5

patient CMV status; 1-CMV positive, 0-CMV negative

Z6

donor CMV status; 1-CMV positive, 0-CMV negative

Z7

waiting time to transplant in days

Z8

FAB; 1-FAB Grade 4 or 5 and AML, 0-Otherwise

Z9

hospital; 1-The Ohio State University, 2-Alfred, 3-St. Vincent, 4-Hahnemann

Z10

MTX used as a graft-versus-host-prophylactic; 1-Yes, 0-No

Source

1. R package "KMsurv".
2. Klein, J. P. and Moeschberger M. L. (2005). Survival Analysis: Techniques for Censored and Truncated Data.

References

Klein, J. P. and Moeschberger M. L. (2005). Survival Analysis: Techniques for Censored and Truncated Data.

Examples

1


SemiCompRisks documentation built on May 19, 2017, 7:51 a.m.
Search within the SemiCompRisks package
Search all R packages, documentation and source code

Questions? Problems? Suggestions? Tweet to @rdrrHQ or email at ian@mutexlabs.com.

Please suggest features or report bugs in the GitHub issue tracker.

All documentation is copyright its authors; we didn't write any of that.